Global Health
- ISIN
- INE474Q01031
- Instrument key
- NSE_EQ|INE474Q01031
as of 21/11/2026, 5:37:01 pm
- Open
- ₹1,476.00
- Day high
- ₹1,509.30
- Day low
- ₹1,472.20
- Prev. close
- ₹1,478.30
- Volume
- 2.65 L
- VWAP
- ₹1,490.44
02/Price history
Price chart
5 years · weekly candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.
- Change · 5Y
- +257.41%414.15 → 1,480.20
- Period high
- ₹1,544.0024/8/2026
- Period low
- ₹390.5514/11/2022
- From high
- -4.13%+279.00% from low
- Avg volume
- 21.41 L44.97 Cr total
- Volatility · ann.
- 34.8%210 candles · 114 up / 96 down
Candle data210 rows of open, high, low, close and volumeShowHide
| 16 Nov 2026 | 1,454.90 | 1,509.30 | 1,424.00 | 1,480.20 | +1.74% | 85.30 | 10.11 L |
| 9 Nov 2026 | 1,396.00 | 1,465.00 | 1,390.80 | 1,454.00 | +4.15% | 74.20 | 8.00 L |
| 2 Nov 2026 | 1,270.30 | 1,451.50 | 1,270.30 | 1,397.50 | +10.01% | 181.20 | 34.23 L |
| 26 Oct 2026 | 1,178.00 | 1,305.00 | 1,170.00 | 1,270.30 | +7.84% | 135.00 | 5.77 L |
| 19 Oct 2026 | 1,240.80 | 1,252.60 | 1,165.00 | 1,185.00 | -4.50% | 87.60 | 10.36 L |
| 12 Oct 2026 | 1,311.90 | 1,322.10 | 1,230.50 | 1,240.00 | -5.48% | 91.60 | 7.58 L |
| 5 Oct 2026 | 1,362.00 | 1,369.10 | 1,258.80 | 1,312.70 | -3.62% | 110.30 | 14.47 L |
| 28 Sept 2026 | 1,490.00 | 1,495.10 | 1,336.20 | 1,357.30 | -8.91% | 158.90 | 11.43 L |
| 21 Sept 2026 | 1,499.40 | 1,527.00 | 1,467.60 | 1,495.40 | -0.27% | 59.40 | 8.74 L |
| 14 Sept 2026 | 1,454.00 | 1,520.00 | 1,380.10 | 1,499.40 | +3.12% | 139.90 | 11.49 L |
Historical price and volume data · Showing 1–10 of 210
03/Valuation & returns
Key ratios vs sector
Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.
Price ÷ earnings per share
Worse than sector by 18%
Price ÷ book value per share
Worse than sector by 202%
Net income ÷ total assets
Better than sector by 121%
Net income ÷ shareholders' equity
Better than sector by 145%
EBIT ÷ capital employed
Better than sector by 35%
Liquid assets ÷ current liabilities
Worse than sector by 92%
Enterprise value ÷ EBITDA
Worse than sector by 44%
04/Business
About the company
Sector: Healthcare Services
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. Medanta provides healthcare services in over 30 medical specialties and engages over 1,800 doctors. Its specialty treatments are in cardiac care, cancer care, neurosciences, orthopedics, renal care, liver transplants, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, ENT, head and neck surgery, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, homecare services, health checkups, elder care, air ambulance, among others. Its subsidiaries include Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.
- ₹39,829 Cr
- $4.43B
reported in crore
reported in billion
Market capitalisation is reported at the sector-constituent level, not the standalone company level.
05/Profit & loss
Consolidated income statement
Quarterly figures in ₹ crore. Growth marked reported is provided; margins are derived.
- Revenue · Sep 2026
- ₹1,493 Cr+12.55% vs Jun 2026
- Net profit · Sep 2026
- ₹219 Cr+39.36% vs Jun 2026
- Operating margin
- 19.8%was 16.1%
- Revenue CAGR · 4p
- 9.3%profit 32.1% · op 35.0%
| Revenue | 1,493 | 1,326 | 1,196 | 1,143 |
|---|---|---|---|---|
| Revenue growthreported | 12.6% | 10.9% | 4.6% | — |
| Operating profit | 295 | 213 | 187 | 120 |
| Operating profit growthreported | 38.3% | 13.9% | 56.4% | — |
| Operating marginderived | 19.8% | 16.1% | 15.7% | 10.5% |
| Net profit | 219 | 157 | 142 | 95 |
| Net profit growthreported | 39.4% | 11.0% | 49.1% | — |
| Net marginderived | 14.7% | 11.9% | 11.8% | 8.3% |
| EPS — basic₹/share, annual | — | — | 20.71 | — |
Figures in ₹ crore. Margin rows are computed from the reported values.
Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
| Revenue | 4,410 | 3,692 | 3,275 | 2,710 |
|---|---|---|---|---|
| Other Income | 99 | 79 | 75 | 49 |
| Total Revenue | 4,509 | 3,771 | 3,350 | 2,759 |
| Total Expenses | 3,793 | 3,074 | 2,723 | 2,310 |
| Profit Before Tax | 715 | 647 | 627 | 449 |
| Tax | 161 | 166 | 149 | 123 |
| Profit After Tax | 554 | 481 | 478 | 326 |
| EPS - Basic | 20.71 | 17.92 | 17.80 | 12.58 |
| EPS - Diluted | 20.66 | 17.92 | 17.80 | 12.57 |
This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.
06/Balance sheet
Consolidated balance sheet
Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.
- Total assets · Mar 2026
- ₹5,905 Cr+23.89% YoY
- Total liabilities
- ₹1,921 Cr
- Net worth
- ₹3,984 Cr
- Liabilities ÷ assets
- 32.5%lower means a lighter balance sheet
| Total assets | 5,905 | 4,766 | 4,304 | 4,116 |
|---|---|---|---|---|
| Total liabilities | 1,921 | 1,379 | 1,398 | 1,688 |
| Net worthderived | 3,984 | 3,388 | 2,906 | 2,428 |
| Liabilities ÷ assetsderived | 32.5% | 28.9% | 32.5% | 41.0% |
| Asset growthderived | 23.9% | 10.7% | 4.6% | — |
Figures in ₹ crore. Stacked chart height equals total assets.
Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
| Non-Current Assets | 4,230 | 3,233 | 2,795 | 2,536 |
|---|---|---|---|---|
| Current Assets | 1,675 | 1,533 | 1,509 | 1,579 |
| Total Assets | 5,905 | 4,766 | 4,304 | 4,116 |
| Current Liabilities | 627 | 619 | 618 | 573 |
| Net Current Asset | 1,048 | 914 | 891 | 1,007 |
| Non-Current Liabilities | 1,294 | 760 | 781 | 1,115 |
| Equity Capital | 3,984 | 3,388 | 2,906 | 2,428 |
| Total Equity & Liabilities | 5,905 | 4,766 | 4,304 | 4,116 |
Figures in ₹ crore unless the line item is per-share.
07/Cash flow
Consolidated cash flow
Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.
- Operating · Mar 2026
- ₹714 Cr+14.53% YoY
- Investing
- -₹1,089 Cr
- Financing
- ₹272 Cr
- Free cash flow
- -₹375 Croperating + investing
| Operating activities | 714 | 624 | 612 | 645 |
|---|---|---|---|---|
| Operating changereported | 14.5% | 1.9% | -5.0% | — |
| Investing activities | -1,089 | -721 | -441 | -342 |
| Investing changereported | -51.1% | -63.5% | -28.8% | — |
| Financing activities | 272 | -97 | -514 | 346 |
| Financing changereported | 379.6% | 81.1% | -248.7% | — |
| Net cash flowderived | -103 | -194 | -343 | 648 |
| Free cash flowoperating + investing | -375 | -97 | 171 | 302 |
Figures in ₹ crore.
Full annual line itemsProfit before tax through closing cash balanceShowHide
| Profit before tax | 715 | 647 | 627 | 449 |
|---|---|---|---|---|
| Income before WC changes | 919 | 888 | 835 | 648 |
| Change in Assets | -152 | -108 | -63 | -8 |
| Change in Liabilities | 67 | 8 | 18 | 111 |
| Change in WC | -85 | -100 | -46 | 103 |
| Cash flow from Operations | 714 | 624 | 612 | 645 |
| Cash flow from Investing | -1,089 | -721 | -441 | -342 |
| Cash flow from Financing | 272 | -97 | -514 | 346 |
| Total Cash Flow | -103 | -194 | -343 | 648 |
| Cash (Start of the year) | 230 | 425 | 767 | 119 |
| Cash (End of the year) | 127 | 230 | 425 | 767 |
Figures in ₹ crore unless the line item is per-share.
09/Events
Corporate actions
Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.
| DividendFinal | ₹0.50 | 25.0% | 14 Aug 2026 | 14 Aug 2026 | 14 May 2026 |
10/Comparison
Peers & competitors
Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.
| APOLLOHOSPApollo Hospitals Enter. L | Healthcare Services | ₹9,200.00 | +5.29% | 14.13 L | ₹1,32,139 Cr | $14.68B | |
| MAXHEALTHMAX Healthcare INS Ltd | Healthcare Services | ₹1,081.00 | +3.88% | 95.32 L | ₹1,05,080 Cr | $11.68B | |
| MANIPALHOSManipal Health Enterpri L | Healthcare | ₹702.20 | +0.83% | 11.62 L | ₹92,366 Cr | $10.26B | |
| ASTERDMAster DM Quality Care Ltd | Healthcare Services | ₹779.30 | +5.41% | 26.66 L | ₹67,960 Cr | $7.55B | |
| FORTISFortis Healthcare Ltd | Healthcare Services | ₹825.00 | +1.87% | 22.88 L | ₹62,284 Cr | $6.92B | |
| NHNarayana Hrudayalaya Ltd. | Healthcare Services | ₹1,945.00 | +3.84% | 7.85 L | ₹39,757 Cr | $4.42B | |
| LALPATHLABDR. LAL Path Labs Ltd. | Healthcare Services | ₹1,989.00 | +1.31% | 2.65 L | ₹33,680 Cr | $3.74B | |
| KIMSKrishna Inst Of MED SCI L | Healthcare Services | ₹795.60 | +3.62% | 10.44 L | ₹33,483 Cr | $3.72B | |
| SYNGENESyngene International Ltd | Diversified | ₹451.70 | +3.28% | 25.58 L | ₹18,240 Cr | $2.03B | |
| MOLBIOMolbio Diagnostics Ltd | Healthcare | ₹1,495.50 | -2.02% | 7.01 L | ₹17,228 Cr | $1.91B |
Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10
11/Coverage
Company news
Articles published in the last seven days, paginated by the provider.
No news in the last seven days
Company news is available for a rolling one-week window.